BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
10 results:

  • 1. Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to cervical Precancer.
    Mukherjee A; Ye Y; Wiener HW; Kuniholm MH; Minkoff H; Michel K; Palefsky J; D'Souza G; Rahangdale L; Butler KR; Kempf MC; Sudenga SL; Aouizerat BE; Ojesina AI; Shrestha S
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1190-1197. PubMed ID: 37410084
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Screening and characterisation of a novel efficient tumour cell-targeting peptide derived from insulin-like growth factor binding proteins.
    He ML; Lei J; Cao XW; Zhao J; Wang FJ
    J Drug Target; 2023 Jun; 31(5):500-510. PubMed ID: 36974745
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Yolk Sac Tumor Originating From cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
    Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
    Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Ultrasound-guided stellate ganglion block accelerates postoperative gastrointestinal function recovery following laparoscopic radical gastrectomy for gastric cancer].
    Li X; Jiang Y; Gu C; Ma S; Cheng X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):300-304. PubMed ID: 35365457
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ELK1-activated gpc3-AS1/gpc3 axis promotes the proliferation and migration of cervical cancer cells.
    Hu R; Zhu Z
    J Gene Med; 2019 Aug; 21(8):e3099. PubMed ID: 31168873
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (ΔNp63) in squamous cell and urothelial carcinoma.
    Gailey MP; Bellizzi AM
    Am J Clin Pathol; 2013 Dec; 140(6):872-80. PubMed ID: 24225756
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antigpc3 probe for hepatocellular carcinoma.
    Li Y; Chen Z; Li F; Wang J; Zhang Z
    Int J Nanomedicine; 2012; 7():4593-611. PubMed ID: 22956868
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma.
    Qiao SS; Cui ZQ; Gong L; Han H; Chen PC; Guo LM; Yu X; Wei YH; Ha SA; Kim JW; Jin ZT; Li S; Peng JR; Leng XS
    Hepatogastroenterology; 2011; 58(110-111):1718-24. PubMed ID: 21940340
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of glypican 3 in placental site trophoblastic tumor.
    Ou-Yang RJ; Hui P; Yang XJ; Zynger DL
    Diagn Pathol; 2010 Sep; 5():64. PubMed ID: 20868507
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.